Clinical Trial Support Services Market 2025-2029

The clinical trial support services market is forecasted to grow by USD 8.91 billion during 2024-2029, accelerating at a CAGR of 7.4% during the forecast period. The report on the clinical trial support services market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growth of biopharmaceutical industry, government initiatives on clinical research, and regulation of clinical trials in regional markets.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The clinical trial support services market is segmented as below:

By Application

Phase 2
Phase 3
Phase 1
Phase 4

By Age Group

Adults (greater than 18 years)
Adolescents (10 to 18 years)
Children (less than 10 years)

By Therapeutic Area

Oncology
Cardiology
Neurology
Infectious diseases
Others

By Geographical Landscape

Europe
North America
Asia
Rest of World (ROW)

This study identifies the growing demand for cros as one of the prime reasons driving the clinical trial support services market growth during the next few years. Also, increase in studies focusing on pharmaceutical industry and rising demand for e-clinical trials will lead to sizable demand in the market.

The report on the clinical trial support services market covers the following areas:

Clinical Trial Support Services Market sizing
Clinical Trial Support Services Market forecast
Clinical Trial Support Services Market industry analysis

A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading clinical trial support services market vendors that include AH UK Holdco 1 Ltd., Almac Group Ltd., Brighter Health Network LLC, Catalent Inc., Charles River Laboratories International Inc., Clinipace Inc., Eli Lilly and Co., Eurofins Scientific SE, ICON plc, IQVIA Holdings Inc., Laboratory Corp. of America Holdings, MARKEN Ltd., Parexel International Corp., Pfizer Inc., Quotient Sciences Ltd., Seveillar Clinical Supplies Services Pvt. Ltd., Syneos Health, Thermo Fisher Scientific Inc., and WuXi AppTec Co. Ltd. Also, the clinical trial support services market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview

Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Application
Executive Summary - Chart on Market Segmentation by Age Group
Executive Summary - Chart on Market Segmentation by Therapeutic Area
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

2.2 Criticality of inputs and Factors of differentiation

Overview on criticality of inputs and factors of differentiation

2.3 Factors of disruption

Overview on factors of disruption

2.4 Impact of drivers and challenges

Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem

Parent Market
Data Table on - Parent Market

3.2 Market characteristics

Market characteristics analysis

3.3 Value chain analysis

Value chain analysis

4 Market Sizing

4.1 Market definition

Offerings of companies included in the market definition

4.2 Market segment analysis

Market segments

4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029

Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Clinical Trial Support Services Market 2019 - 2023

Historic Market Size - Data Table on Global Clinical Trial Support Services Market 2019 - 2023 ($ million)

5.2 Application segment analysis 2019 - 2023

Historic Market Size - Application Segment 2019 - 2023 ($ million)

5.3 Age Group segment analysis 2019 - 2023

Historic Market Size - Age Group Segment 2019 - 2023 ($ million)

5.4 Therapeutic Area segment analysis 2019 - 2023

Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)

5.5 Geography segment analysis 2019 - 2023

Historic Market Size - Geography Segment 2019 - 2023 ($ million)

5.6 Country segment analysis 2019 - 2023

Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 The impact of AI in the global clinical trial support services market

7 Five Forces Analysis

7.1 Five forces summary

Five forces analysis - Comparison between 2024 and 2029

7.2 Bargaining power of buyers

Bargaining power of buyers - Impact of key factors 2024 and 2029

7.3 Bargaining power of suppliers

Bargaining power of suppliers - Impact of key factors in 2024 and 2029

7.4 Threat of new entrants

Threat of new entrants - Impact of key factors in 2024 and 2029

7.5 Threat of substitutes

Threat of substitutes - Impact of key factors in 2024 and 2029

7.6 Threat of rivalry

Threat of rivalry - Impact of key factors in 2024 and 2029

7.7 Market condition

Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Application

8.1 Market segments

Chart on Application - Market share 2024-2029 (%)
Data Table on Application - Market share 2024-2029 (%)

8.2 Comparison by Application

Chart on Comparison by Application
Data Table on Comparison by Application

8.3 Phase 2 - Market size and forecast 2024-2029

Chart on Phase 2 - Market size and forecast 2024-2029 ($ million)
Data Table on Phase 2 - Market size and forecast 2024-2029 ($ million)
Chart on Phase 2 - Year-over-year growth 2024-2029 (%)
Data Table on Phase 2 - Year-over-year growth 2024-2029 (%)

8.4 Phase 3 - Market size and forecast 2024-2029

Chart on Phase 3 - Market size and forecast 2024-2029 ($ million)
Data Table on Phase 3 - Market size and forecast 2024-2029 ($ million)
Chart on Phase 3 - Year-over-year growth 2024-2029 (%)
Data Table on Phase 3 - Year-over-year growth 2024-2029 (%)

8.5 Phase 1 - Market size and forecast 2024-2029

Chart on Phase 1 - Market size and forecast 2024-2029 ($ million)
Data Table on Phase 1 - Market size and forecast 2024-2029 ($ million)
Chart on Phase 1 - Year-over-year growth 2024-2029 (%)
Data Table on Phase 1 - Year-over-year growth 2024-2029 (%)

8.6 Phase 4 - Market size and forecast 2024-2029

Chart on Phase 4 - Market size and forecast 2024-2029 ($ million)
Data Table on Phase 4 - Market size and forecast 2024-2029 ($ million)
Chart on Phase 4 - Year-over-year growth 2024-2029 (%)
Data Table on Phase 4 - Year-over-year growth 2024-2029 (%)

8.7 Market opportunity by Application

Market opportunity by Application ($ million)
Data Table on Market opportunity by Application ($ million)

9 Market Segmentation by Age Group

9.1 Market segments

Chart on Age Group - Market share 2024-2029 (%)
Data Table on Age Group - Market share 2024-2029 (%)

9.2 Comparison by Age Group

Chart on Comparison by Age Group
Data Table on Comparison by Age Group

9.3 Adults (greater than 18 years) - Market size and forecast 2024-2029

Chart on Adults (greater than 18 years) - Market size and forecast 2024-2029 ($ million)
Data Table on Adults (greater than 18 years) - Market size and forecast 2024-2029 ($ million)
Chart on Adults (greater than 18 years) - Year-over-year growth 2024-2029 (%)
Data Table on Adults (greater than 18 years) - Year-over-year growth 2024-2029 (%)

9.4 Adolescents (10 to 18 years) - Market size and forecast 2024-2029

Chart on Adolescents (10 to 18 years) - Market size and forecast 2024-2029 ($ million)
Data Table on Adolescents (10 to 18 years) - Market size and forecast 2024-2029 ($ million)
Chart on Adolescents (10 to 18 years) - Year-over-year growth 2024-2029 (%)
Data Table on Adolescents (10 to 18 years) - Year-over-year growth 2024-2029 (%)

9.5 Children (less than 10 years) - Market size and forecast 2024-2029

Chart on Children (less than 10 years) - Market size and forecast 2024-2029 ($ million)
Data Table on Children (less than 10 years) - Market size and forecast 2024-2029 ($ million)
Chart on Children (less than 10 years) - Year-over-year growth 2024-2029 (%)
Data Table on Children (less than 10 years) - Year-over-year growth 2024-2029 (%)

9.6 Market opportunity by Age Group

Market opportunity by Age Group ($ million)
Data Table on Market opportunity by Age Group ($ million)

10 Market Segmentation by Therapeutic Area

10.1 Market segments

Chart on Therapeutic Area - Market share 2024-2029 (%)
Data Table on Therapeutic Area - Market share 2024-2029 (%)

10.2 Comparison by Therapeutic Area

Chart on Comparison by Therapeutic Area
Data Table on Comparison by Therapeutic Area

10.3 Oncology - Market size and forecast 2024-2029

Chart on Oncology - Market size and forecast 2024-2029 ($ million)
Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
Chart on Oncology - Year-over-year growth 2024-2029 (%)
Data Table on Oncology - Year-over-year growth 2024-2029 (%)

10.4 Cardiology - Market size and forecast 2024-2029

Chart on Cardiology - Market size and forecast 2024-2029 ($ million)
Data Table on Cardiology - Market size and forecast 2024-2029 ($ million)
Chart on Cardiology - Year-over-year growth 2024-2029 (%)
Data Table on Cardiology - Year-over-year growth 2024-2029 (%)

10.5 Neurology - Market size and forecast 2024-2029

Chart on Neurology - Market size and forecast 2024-2029 ($ million)
Data Table on Neurology - Market size and forecast 2024-2029 ($ million)
Chart on Neurology - Year-over-year growth 2024-2029 (%)
Data Table on Neurology - Year-over-year growth 2024-2029 (%)

10.6 Infectious diseases - Market size and forecast 2024-2029

Chart on Infectious diseases - Market size and forecast 2024-2029 ($ million)
Data Table on Infectious diseases - Market size and forecast 2024-2029 ($ million)
Chart on Infectious diseases - Year-over-year growth 2024-2029 (%)
Data Table on Infectious diseases - Year-over-year growth 2024-2029 (%)

10.7 Others - Market size and forecast 2024-2029

Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)

10.8 Market opportunity by Therapeutic Area

Market opportunity by Therapeutic Area ($ million)
Data Table on Market opportunity by Therapeutic Area ($ million)

11 Customer Landscape

11.1 Customer landscape overview

Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation

Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)

12.2 Geographic comparison

Chart on Geographic comparison
Data Table on Geographic comparison

12.3 Europe - Market size and forecast 2024-2029

Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)

12.4 North America - Market size and forecast 2024-2029

Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)

12.5 Asia - Market size and forecast 2024-2029

Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)

12.6 Rest of World (ROW) - Market size and forecast 2024-2029

Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)

12.7 US - Market size and forecast 2024-2029

Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)

12.8 Japan - Market size and forecast 2024-2029

Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)

12.9 China - Market size and forecast 2024-2029

Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)

12.10 Germany - Market size and forecast 2024-2029

Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)

12.11 Brazil - Market size and forecast 2024-2029

Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Chart on Brazil - Year-over-year growth 2024-2029 (%)
Data Table on Brazil - Year-over-year growth 2024-2029 (%)

12.12 France - Market size and forecast 2024-2029

Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)

12.13 India - Market size and forecast 2024-2029

Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)

12.14 UK - Market size and forecast 2024-2029

Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)

12.15 Italy - Market size and forecast 2024-2029

Chart on Italy - Market size and forecast 2024-2029 ($ million)
Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Chart on Italy - Year-over-year growth 2024-2029 (%)
Data Table on Italy - Year-over-year growth 2024-2029 (%)

12.16 South Korea - Market size and forecast 2024-2029

Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Chart on South Korea - Year-over-year growth 2024-2029 (%)
Data Table on South Korea - Year-over-year growth 2024-2029 (%)

12.17 Market opportunity By Geographical Landscape

Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges

Impact of drivers and challenges in 2024 and 2029

13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape

Overview on criticality of inputs and factors of differentiation

14.3 Landscape disruption

Overview on factors of disruption

14.4 Industry risks

Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled

Companies covered

15.2 Company ranking index

Company ranking index

15.3 Market positioning of companies

Matrix on companies position and classification

15.4 AH UK Holdco 1 Ltd.

AH UK Holdco 1 Ltd. - Overview
AH UK Holdco 1 Ltd. - Product / Service
AH UK Holdco 1 Ltd. - Key offerings
SWOT

15.5 Almac Group Ltd.

Almac Group Ltd. - Overview
Almac Group Ltd. - Product / Service
Almac Group Ltd. - Key offerings
SWOT

15.6 Catalent Inc.

Catalent Inc. - Overview
Catalent Inc. - Business segments
Catalent Inc. - Key offerings
Catalent Inc. - Segment focus
SWOT

15.7 Charles River Laboratories International Inc.

Charles River Laboratories International Inc. - Overview
Charles River Laboratories International Inc. - Business segments
Charles River Laboratories International Inc. - Key offerings
Charles River Laboratories International Inc. - Segment focus
SWOT

15.8 Eli Lilly and Co.

Eli Lilly and Co. - Overview
Eli Lilly and Co. - Product / Service
Eli Lilly and Co. - Key offerings
SWOT

15.9 Eurofins Scientific SE

Eurofins Scientific SE - Overview
Eurofins Scientific SE - Business segments
Eurofins Scientific SE - Key offerings
Eurofins Scientific SE - Segment focus
SWOT

15.10 ICON plc

ICON plc - Overview
ICON plc - Product / Service
ICON plc - Key offerings
SWOT

15.11 IQVIA Holdings Inc.

IQVIA Holdings Inc. - Overview
IQVIA Holdings Inc. - Business segments
IQVIA Holdings Inc. - Key offerings
IQVIA Holdings Inc. - Segment focus
SWOT

15.12 Laboratory Corp. of America Holdings

Laboratory Corp. of America Holdings - Overview
Laboratory Corp. of America Holdings - Business segments
Laboratory Corp. of America Holdings - Key news
Laboratory Corp. of America Holdings - Key offerings
Laboratory Corp. of America Holdings - Segment focus
SWOT

15.13 Parexel International Corp.

Parexel International Corp. - Overview
Parexel International Corp. - Product / Service
Parexel International Corp. - Key offerings
SWOT

15.14 Pfizer Inc.

Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT

15.15 Quotient Sciences Ltd.

Quotient Sciences Ltd. - Overview
Quotient Sciences Ltd. - Product / Service
Quotient Sciences Ltd. - Key offerings
SWOT

15.16 Syneos Health

Syneos Health - Overview
Syneos Health - Product / Service
Syneos Health - Key offerings
SWOT

15.17 Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. - Overview
Thermo Fisher Scientific Inc. - Business segments
Thermo Fisher Scientific Inc. - Key news
Thermo Fisher Scientific Inc. - Key offerings
Thermo Fisher Scientific Inc. - Segment focus
SWOT

15.18 WuXi AppTec Co. Ltd.

WuXi AppTec Co. Ltd. - Overview
WuXi AppTec Co. Ltd. - Business segments
WuXi AppTec Co. Ltd. - Key offerings
WuXi AppTec Co. Ltd. - Segment focus
SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist

Inclusions checklist
Exclusions checklist

16.3 Currency conversion rates for US$

Currency conversion rates for US$

16.4 Research methodology

Research methodology

16.5 Data procurement

Information sources

16.6 Data validation

Data validation

16.7 Validation techniques employed for market sizing

Validation techniques employed for market sizing

16.8 Data synthesis

Data synthesis

16.9 360 degree market analysis

360 degree market analysis

16.10 List of abbreviations

List of abbreviations

List of Exhibits

Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Application
Exhibits 6: Executive Summary - Chart on Market Segmentation by Age Group
Exhibits 7: Executive Summary - Chart on Market Segmentation by Therapeutic Area
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Historic Market Size - Data Table on Global Clinical Trial Support Services Market 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - Application Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Age Group Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Therapeutic Area Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 31: Five forces analysis - Comparison between 2024 and 2029
Exhibits 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 37: Chart on Market condition - Five forces 2024 and 2029
Exhibits 38: Chart on Application - Market share 2024-2029 (%)
Exhibits 39: Data Table on Application - Market share 2024-2029 (%)
Exhibits 40: Chart on Comparison by Application
Exhibits 41: Data Table on Comparison by Application
Exhibits 42: Chart on Phase 2 - Market size and forecast 2024-2029 ($ million)
Exhibits 43: Data Table on Phase 2 - Market size and forecast 2024-2029 ($ million)
Exhibits 44: Chart on Phase 2 - Year-over-year growth 2024-2029 (%)
Exhibits 45: Data Table on Phase 2 - Year-over-year growth 2024-2029 (%)
Exhibits 46: Chart on Phase 3 - Market size and forecast 2024-2029 ($ million)
Exhibits 47: Data Table on Phase 3 - Market size and forecast 2024-2029 ($ million)
Exhibits 48: Chart on Phase 3 - Year-over-year growth 2024-2029 (%)
Exhibits 49: Data Table on Phase 3 - Year-over-year growth 2024-2029 (%)
Exhibits 50: Chart on Phase 1 - Market size and forecast 2024-2029 ($ million)
Exhibits 51: Data Table on Phase 1 - Market size and forecast 2024-2029 ($ million)
Exhibits 52: Chart on Phase 1 - Year-over-year growth 2024-2029 (%)
Exhibits 53: Data Table on Phase 1 - Year-over-year growth 2024-2029 (%)
Exhibits 54: Chart on Phase 4 - Market size and forecast 2024-2029 ($ million)
Exhibits 55: Data Table on Phase 4 - Market size and forecast 2024-2029 ($ million)
Exhibits 56: Chart on Phase 4 - Year-over-year growth 2024-2029 (%)
Exhibits 57: Data Table on Phase 4 - Year-over-year growth 2024-2029 (%)
Exhibits 58: Market opportunity by Application ($ million)
Exhibits 59: Data Table on Market opportunity by Application ($ million)
Exhibits 60: Chart on Age Group - Market share 2024-2029 (%)
Exhibits 61: Data Table on Age Group - Market share 2024-2029 (%)
Exhibits 62: Chart on Comparison by Age Group
Exhibits 63: Data Table on Comparison by Age Group
Exhibits 64: Chart on Adults (greater than 18 years) - Market size and forecast 2024-2029 ($ million)
Exhibits 65: Data Table on Adults (greater than 18 years) - Market size and forecast 2024-2029 ($ million)
Exhibits 66: Chart on Adults (greater than 18 years) - Year-over-year growth 2024-2029 (%)
Exhibits 67: Data Table on Adults (greater than 18 years) - Year-over-year growth 2024-2029 (%)
Exhibits 68: Chart on Adolescents (10 to 18 years) - Market size and forecast 2024-2029 ($ million)
Exhibits 69: Data Table on Adolescents (10 to 18 years) - Market size and forecast 2024-2029 ($ million)
Exhibits 70: Chart on Adolescents (10 to 18 years) - Year-over-year growth 2024-2029 (%)
Exhibits 71: Data Table on Adolescents (10 to 18 years) - Year-over-year growth 2024-2029 (%)
Exhibits 72: Chart on Children (less than 10 years) - Market size and forecast 2024-2029 ($ million)
Exhibits 73: Data Table on Children (less than 10 years) - Market size and forecast 2024-2029 ($ million)
Exhibits 74: Chart on Children (less than 10 years) - Year-over-year growth 2024-2029 (%)
Exhibits 75: Data Table on Children (less than 10 years) - Year-over-year growth 2024-2029 (%)
Exhibits 76: Market opportunity by Age Group ($ million)
Exhibits 77: Data Table on Market opportunity by Age Group ($ million)
Exhibits 78: Chart on Therapeutic Area - Market share 2024-2029 (%)
Exhibits 79: Data Table on Therapeutic Area - Market share 2024-2029 (%)
Exhibits 80: Chart on Comparison by Therapeutic Area
Exhibits 81: Data Table on Comparison by Therapeutic Area
Exhibits 82: Chart on Oncology - Market size and forecast 2024-2029 ($ million)
Exhibits 83: Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
Exhibits 84: Chart on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits 85: Data Table on Oncology - Year-over-year growth 2024-2029 (%)
Exhibits 86: Chart on Cardiology - Market size and forecast 2024-2029 ($ million)
Exhibits 87: Data Table on Cardiology - Market size and forecast 2024-2029 ($ million)
Exhibits 88: Chart on Cardiology - Year-over-year growth 2024-2029 (%)
Exhibits 89: Data Table on Cardiology - Year-over-year growth 2024-2029 (%)
Exhibits 90: Chart on Neurology - Market size and forecast 2024-2029 ($ million)
Exhibits 91: Data Table on Neurology - Market size and forecast 2024-2029 ($ million)
Exhibits 92: Chart on Neurology - Year-over-year growth 2024-2029 (%)
Exhibits 93: Data Table on Neurology - Year-over-year growth 2024-2029 (%)
Exhibits 94: Chart on Infectious diseases - Market size and forecast 2024-2029 ($ million)
Exhibits 95: Data Table on Infectious diseases - Market size and forecast 2024-2029 ($ million)
Exhibits 96: Chart on Infectious diseases - Year-over-year growth 2024-2029 (%)
Exhibits 97: Data Table on Infectious diseases - Year-over-year growth 2024-2029 (%)
Exhibits 98: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 99: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 100: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 101: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 102: Market opportunity by Therapeutic Area ($ million)
Exhibits 103: Data Table on Market opportunity by Therapeutic Area ($ million)
Exhibits 104: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 105: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 106: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 107: Chart on Geographic comparison
Exhibits 108: Data Table on Geographic comparison
Exhibits 109: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 146: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 147: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 149: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits 150: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits 151: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 152: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 153: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 154: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 155: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 156: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 157: Chart on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 158: Data Table on Italy - Market size and forecast 2024-2029 ($ million)
Exhibits 159: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 160: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits 161: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits 162: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits 163: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits 164: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits 165: Market opportunity By Geographical Landscape ($ million)
Exhibits 166: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 167: Impact of drivers and challenges in 2024 and 2029
Exhibits 168: Overview on criticality of inputs and factors of differentiation
Exhibits 169: Overview on factors of disruption
Exhibits 170: Impact of key risks on business
Exhibits 171: Companies covered
Exhibits 172: Company ranking index
Exhibits 173: Matrix on companies position and classification
Exhibits 174: AH UK Holdco 1 Ltd. - Overview
Exhibits 175: AH UK Holdco 1 Ltd. - Product / Service
Exhibits 176: AH UK Holdco 1 Ltd. - Key offerings
Exhibits 177: SWOT
Exhibits 178: Almac Group Ltd. - Overview
Exhibits 179: Almac Group Ltd. - Product / Service
Exhibits 180: Almac Group Ltd. - Key offerings
Exhibits 181: SWOT
Exhibits 182: Catalent Inc. - Overview
Exhibits 183: Catalent Inc. - Business segments
Exhibits 184: Catalent Inc. - Key offerings
Exhibits 185: Catalent Inc. - Segment focus
Exhibits 186: SWOT
Exhibits 187: Charles River Laboratories International Inc. - Overview
Exhibits 188: Charles River Laboratories International Inc. - Business segments
Exhibits 189: Charles River Laboratories International Inc. - Key offerings
Exhibits 190: Charles River Laboratories International Inc. - Segment focus
Exhibits 191: SWOT
Exhibits 192: Eli Lilly and Co. - Overview
Exhibits 193: Eli Lilly and Co. - Product / Service
Exhibits 194: Eli Lilly and Co. - Key offerings
Exhibits 195: SWOT
Exhibits 196: Eurofins Scientific SE - Overview
Exhibits 197: Eurofins Scientific SE - Business segments
Exhibits 198: Eurofins Scientific SE - Key offerings
Exhibits 199: Eurofins Scientific SE - Segment focus
Exhibits 200: SWOT
Exhibits 201: ICON plc - Overview
Exhibits 202: ICON plc - Product / Service
Exhibits 203: ICON plc - Key offerings
Exhibits 204: SWOT
Exhibits 205: IQVIA Holdings Inc. - Overview
Exhibits 206: IQVIA Holdings Inc. - Business segments
Exhibits 207: IQVIA Holdings Inc. - Key offerings
Exhibits 208: IQVIA Holdings Inc. - Segment focus
Exhibits 209: SWOT
Exhibits 210: Laboratory Corp. of America Holdings - Overview
Exhibits 211: Laboratory Corp. of America Holdings - Business segments
Exhibits 212: Laboratory Corp. of America Holdings - Key news
Exhibits 213: Laboratory Corp. of America Holdings - Key offerings
Exhibits 214: Laboratory Corp. of America Holdings - Segment focus
Exhibits 215: SWOT
Exhibits 216: Parexel International Corp. - Overview
Exhibits 217: Parexel International Corp. - Product / Service
Exhibits 218: Parexel International Corp. - Key offerings
Exhibits 219: SWOT
Exhibits 220: Pfizer Inc. - Overview
Exhibits 221: Pfizer Inc. - Product / Service
Exhibits 222: Pfizer Inc. - Key news
Exhibits 223: Pfizer Inc. - Key offerings
Exhibits 224: SWOT
Exhibits 225: Quotient Sciences Ltd. - Overview
Exhibits 226: Quotient Sciences Ltd. - Product / Service
Exhibits 227: Quotient Sciences Ltd. - Key offerings
Exhibits 228: SWOT
Exhibits 229: Syneos Health - Overview
Exhibits 230: Syneos Health - Product / Service
Exhibits 231: Syneos Health - Key offerings
Exhibits 232: SWOT
Exhibits 233: Thermo Fisher Scientific Inc. - Overview
Exhibits 234: Thermo Fisher Scientific Inc. - Business segments
Exhibits 235: Thermo Fisher Scientific Inc. - Key news
Exhibits 236: Thermo Fisher Scientific Inc. - Key offerings
Exhibits 237: Thermo Fisher Scientific Inc. - Segment focus
Exhibits 238: SWOT
Exhibits 239: WuXi AppTec Co. Ltd. - Overview
Exhibits 240: WuXi AppTec Co. Ltd. - Business segments
Exhibits 241: WuXi AppTec Co. Ltd. - Key offerings
Exhibits 242: WuXi AppTec Co. Ltd. - Segment focus
Exhibits 243: SWOT
Exhibits 244: Inclusions checklist
Exhibits 245: Exclusions checklist
Exhibits 246: Currency conversion rates for US$
Exhibits 247: Research methodology
Exhibits 248: Information sources
Exhibits 249: Data validation
Exhibits 250: Validation techniques employed for market sizing
Exhibits 251: Data synthesis
Exhibits 252: 360 degree market analysis
Exhibits 253: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global clinical trial support services market: AH UK Holdco 1 Ltd., Almac Group Ltd., Brighter Health Network LLC, Catalent Inc., Charles River Laboratories International Inc., Clinipace Inc., Eli Lilly and Co., Eurofins Scientific SE, ICON plc, IQVIA Holdings Inc., Laboratory Corp. of America Holdings, MARKEN Ltd., Parexel International Corp., Pfizer Inc., Quotient Sciences Ltd., Seveillar Clinical Supplies Services Pvt. Ltd., Syneos Health, Thermo Fisher Scientific Inc., and WuXi AppTec Co. Ltd..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is growing demand for cros."

According to the report, one of the major drivers for this market is the growth of biopharmaceutical industry.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

AH UK Holdco 1 Ltd.
Almac Group Ltd.
Brighter Health Network LLC
Catalent Inc.
Charles River Laboratories International Inc.
Clinipace Inc.
Eli Lilly and Co.
Eurofins Scientific SE
ICON plc
IQVIA Holdings Inc.
Laboratory Corp. of America Holdings
MARKEN Ltd.
Parexel International Corp.
Pfizer Inc.
Quotient Sciences Ltd.
Seveillar Clinical Supplies Services Pvt. Ltd.
Syneos Health
Thermo Fisher Scientific Inc.
WuXi AppTec Co. Ltd.

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€2203EUR$2,500USD£1,898GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€3524EUR$4,000USD£3,037GBP

The clinical trial support services market is segmented as below:

By Application

By Age Group

By Therapeutic Area

By Geographical Landscape

The report on the clinical trial support services market covers the following areas:

Table of Contents

Executive Summary

Companies Mentioned (Partial List)

Related Topics

Related Reports

Clinical Trial Support Services Global Market Report 2025

Clinical Trials Support Services Market Size, Share & Trends Analysis Report By Phases, By Service, By Sponsor, By Region, And Segment Forecasts, 2025 - 2030

Clinical Trial Support Services Market by Service Type, Execution Model, Therapeutic Area, Phase, Trial Design, Sponsor Type - Global Forecast to 2030

Clinical Trials Support Services - Global Strategic Business Report

2025 Global Forecast for Clinical Trial Support Service Market (2026-2031 Outlook)-High Tech Outlook Report